Finally, we demonstrated that the RAD51 assay is feasible in formalin‐fixed paraffin‐embedded (FFPE) routine breast cancer samples and accurately classified as HRR‐deficient all the PALB2‐related tumors. Here, PALB2 is linked to breast cancer.